Items tagged with Access

Stop TB Partnership launches the Challenge Facility for Civil Society 2019 (post with simple image)

The largest-ever call for proposals for community and civil society for a TB response that is rights-based, gender-transformative, people-centered and accountable is announced.

Sanofi withdraws two patent applications on life-saving TB prevention drugs in Europe and in Indonesia (post with simple image)

Activists urge Sanofi to do the same in other countries.

MSF calls on Johnson & Johnson to lower price of lifesaving TB drug (post with simple image)

Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.

World TB Day 2020: It's Time To End TB! (post with simple image)

WHO advocacy and communications package to support awareness building and drive action across all levels, in the lead up to and on World TB Day.

TAG statement on the high price of Cepheid’s Xpert test for COVID-19 (post with simple image)

Cepheid is profiteering during a pandemic, with dangerous consequences for countries with vulnerable populations and health systems.

Civil society call for equitable and affordable access to COVID-19 and related diagnostics (post with simple image)

Advocates call for a higher level of global coordination, transparency, and accountability to ensure sustainable and equitable access to testing.

Stop TB Partnership and Johnson & Johnson announce price reduction for bedaquiline (post with simple image)

Stop TB Partnership and Johnson & Johnson, with support from USAID and the Global Fund, announce price reduction for bedaquiline for treatment of drug-resistant TB in low- and middle-income countries.

Johnson & Johnson TB drug price reduction is important step, and governments need to urgently scale up better treatment (post with simple image)

120,707 people signed petitions urging the corporation to drop the price.

Treatment Action Group statement on bedaquiline unaffordability (post with simple image)

Bedaquiline is a public good, and must be treated as such. Johnson & Johnson once again refused to meet evidence-based demands to price bedaquiline at $1/day.

TB CAB Statement (post with simple image)

TB CAB Access Considerations Statement Regarding Johnson & Johnson Announcement of Bedaquiline Price Reduction

Page 75 of 83 · Total posts: 0

←First 74 75 76 Last→